Translate
Amicus Therapeutics Inc
About
Amicus Therapeutics Inc (NASDAQ:FOLD) — investor relations, events, news, and company updates on 6ix.
Latest News
Feb 23 2026
BioMarin Reports Fourth Quarter and Full-year 2025 Financial and Operating Results
Feb 20 2026
Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates
Feb 12 2026
BioMarin Announces Closing of Private Offering of Senior Notes
Feb 3 2026
Amicus Therapeutics Presents New Long-term Data for both Galafold® (migalastat) and POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at the 22nd Annual WORLDSymposium™ 2026
Jan 29 2026
BioMarin Announces Pricing of Private Offering of Senior Notes and Completion of Syndication of New Senior Secured Term Loan Facility